American Oriental Bioengineering (AOBI) Stock Price, News & Analysis

Company Overview

American Oriental Bioengineering Inc (OTCMKTS:AOBI) is a biotechnology company specializing in the research, development and manufacturing of recombinant human type I collagen. The company’s proprietary fermentation-based production process yields high-purity, biocompatible collagen that serves as the basis for a range of wound care, cosmetic and biomedical applications.

American Oriental Bioengineering’s product portfolio includes advanced wound-healing dressings, dermal fillers, oral care formulations and tissue-engineering scaffolds. Through partnerships with pharmaceutical and medical device firms as well as cosmetics manufacturers, its collagen materials are incorporated into products designed to accelerate tissue repair, enhance skin regeneration and support regenerative medicine therapies.

Headquartered in China, the company operates research and production facilities that supply markets in Asia, Europe and North America via direct sales and distributor networks. With ongoing investment in research and development and collaborations with academic institutions and industry partners, American Oriental Bioengineering is pursuing expanded applications in orthopedics, aesthetic medicine and other emerging areas of regenerative health care.

Key Stats

• Today's Range: $0.0012 to $0.0012
• 50-Day Range: N/A
• 52-Week Range: $0.0011 to $0.0012
• Volume: N/A
• Average Volume: 45 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AOBI Stock Analysis - Frequently Asked Questions

How have AOBI shares performed this year?

American Oriental Bioengineering's stock was trading at $0.0005 at the beginning of the year. Since then, AOBI shares have increased by 140.0% and is now trading at $0.0012.

How do I buy shares of American Oriental Bioengineering?

Shares of AOBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of American Oriental Bioengineering own?

Based on aggregate information from My MarketBeat watchlists, some other companies that American Oriental Bioengineering investors own include Armata Pharmaceuticals (ARMP), Aurora Cannabis (ACB), ACADIA Pharmaceuticals (ACAD), Arbutus Biopharma (ABUS), Abacus Property Group (ABP), Advanced Biomedical Technologies (ABMT) and Abiomed (ABMD).

Company Calendar

• Today: 10/23/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:AOBI
• Previous Symbol: NYSE:AOB
• CIK: N/A
• Web: www.bioaobo.com
• Phone: 861059822039
• Fax: 86-10-5982-2039
• Employees: 3,720
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 8.57